அறுவை சிகிச்சை ஹீமோஸ்டாட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அறுவை சிகிச்சை ஹீமோஸ்டாட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அறுவை சிகிச்சை ஹீமோஸ்டாட் Today - Breaking & Trending Today

Arch Therapeutics' AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium .
Arch Therapeutics, Inc.May 10, 2021 GMT
FRAMINGHAM, Mass., May 10, 2021 (GLOBE NEWSWIRE) Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, presents two clinical case reports supporting the broad potential of AC5
® Advanced Wound System in chronic and non-healing wounds at the 2021 Symposium on Advanced Wound Care (SAWC) Spring this week. Both abstracts are available as Poster Presentations, and one abstract qualified for Podium Presentation in the Rapid Fire Symposium and earned a ribbon designation in the Poster Hall as the 2021 Highest Scoring Poster Abstract in the “Case Series/Study” category. ....

United States , Danielc Wadsworth , Daniel Wadsworth , Terrencew Norchi , Michael Abrams , Dermal Sciences , Drug Administration , Securities Exchange , Meeting Site Of The Wound Healing Society , Arch Therapeutics Inc , Advanced Wound System , Advanced Wound Care , Poster Presentations , Podium Presentation , Rapid Fire Symposium , Poster Hall , Scoring Poster Abstract , Wound System , Topical Hemostat , Chronic Trophic Ulcer , Peripheral Vascular , Autoimmune Comorbidities , Kalpana Kamath Phd , Daniel Kapp , Hall Ribbon Designation , Scoring Poster Abstract Case ,

Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11


Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 – 14, 2021
FRAMINGHAM, Mass., Jan. 05, 2021 Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, announced today that it will be presenting at the H.C. Wainwright BioConnect Conference, which will be held January 11-14, 2021.
Chief Executive Officer, Terrence W. Norchi, MD, and Chief Financial Officer, Richard Davis, are scheduled to present via webcast, which will be available on-demand as of 6:00 AM ET, Monday, Jan. 11, 2021. 
Conference attendees may request meetings with management here: https://hcwevents.com/bioconnect/.
After the event, the presentation will be available here: https://ir.archtherapeutics.com/presentations. ....

United States , Hc Wainwright Bioconnect , Terrencew Norchi , Richard Davis , Securities Exchange , Arch Therapeutics Inc , Arch Therapeutics , Bioconnect Conference , Executive Officer , Chief Financial Officer , Advanced Wound System , Surgical Hemostat , Regarding Forward Looking Statements This , Securities Act , Securities Exchange Act , Relations Toll Free , Davis Chief Financial Officer Arch Therapeutics , Wound System , ஒன்றுபட்டது மாநிலங்களில் , ரிச்சர்ட் டேவிஸ் , பத்திரங்கள் பரிமாற்றம் , வளைவு சிகிச்சை இன்க் , வளைவு சிகிச்சை , நிர்வாகி அதிகாரி , தலைமை நிதி அதிகாரி , அறுவை சிகிச்சை ஹீமோஸ்டாட் ,